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What’s Known on This Subject
Viral respiratory tract infections cause severe respiratory morbidity in ex-preterm infants after
NICU discharge. They are now recognized to be more prevalent in the NICU but their long-
term impact, prior to discharge, during this early period of life is unclear.
What This Study Adds
This study identifies the adverse impact viral respiratory infections, particularly rhinovirus,
have on newborn infants during their initial NICU admission. Identification of the associated
significant respiratory morbidity and healthcare costs should focus efforts on reducing these
nosocomially acquired infections.
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ABSTRACT
Background Neonatal respiratory disease, particularly bronchopulmonary dysplasia, remains
one of the leading causes of morbidity and mortality in newborn infants. There is increasing
evidence that nosocomially acquired viral respiratory tract infections (VRTIs) are not
uncommon in the neonatal intensive care unit but there are few studies on their impact on
neonatal respiratory outcomes and the associated healthcare costs. This study aimed to assess
the association between nosocomial VRTI and neonatal respiratory disease.
Methods A matched case-control study was conducted in two tertiary neonatal intensive care
units during a 6 year period in Nottingham, UK. Cases were symptomatic neonatal patients
with a confirmed real-time PCR diagnosis of a VRTI. Matched controls (gestation and
centre) had never tested positive for a VRTI. Multivariable logistic regression was used to
test for associations with key respiratory outcomes.
Results There were 7995 admissions during the study period with 92 cases matched to 183
controls. Baseline characteristics were similar with a median gestation of 29 weeks.
Rhinovirus was found in 74% of VRTIs. During VRTIs, 51% of infants needed escalation of
respiratory support and cases required significantly more respiratory pressure support overall
(25 vs. 7 days, P<0.001). Cases spent longer in hospital (76 vs. 41 days, P<0.001), twice as
many required home oxygen (37%, OR 3.94, 95% CI 1.92-8.06, P<0.001) and in-hospital
care costs were significantly more (£49,664 ($71,861) vs. £22,155 ($32,057), P<0.001).
Conclusion Nosocomial VRTI in neonatal patients is associated with significant greater
respiratory morbidity and healthcare costs. Prevention efforts must be explored.
INTRODUCTION
Neonatal bronchopulmonary dysplasia (BDP) is associated with long-term respiratory
morbidity, including asthma, chronic obstructive airways disease1-3, and poor
neurodevelopmental outcomes4. Despite improvements in the respiratory management of
preterm infants, and subsequent increased survival, many countries have not seen reductions
in BPD. In the UK, 68% of extremely preterm survivors born in 2006 had BPD, unchanged
from 1995 rates5. Current US estimates suggest there are between 5000 and 10000 new cases
of BPD annually2, with respiratory causes of death are second only to immaturity in
extremely preterm infants6.
The pathogenesis of BPD is multifactorial with the presence of inflammation and prematurity
key factors. The inflammatory changes observed are usually a result of infection, ventilatory
trauma and hyperoxia7. Few studies have explored the role of viral respiratory tract infection
(VRTI) in this process although animal studies have highlighted their potential adverse role7,8.
Following discharge from the neonatal intensive care unit (NICU), surviving preterm infants
with subsequent VRTIs are more likely to develop severe respiratory disease or suffer from
recurrent wheeze and asthma9-11.
Nosocomial VRTIs are often unrecognised or clinically underdiagnosed in the NICU12,13 with
up to 52% of admissions testing positive for viral DNA by PCR14. Therefore, it is plausible
that VRTIs acquired during the NICU period could worsen BPD in preterm infants although
previous studies have mostly been small observational studies12,13,15-19. We aimed to assess
the association between nosocomial VRTIs acquired in the NICU and respiratory morbidity
up to hospital discharge.
METHODS
Study design
This was a retrospective matched case-control study conducted in two large tertiary NICUs in
Nottingham, UK, between July 2007 and July 2013 which included the worldwide influenza
A (H1N1) pandemic in 2009/10. This timeframe was chosen as it represented the start of
detailed electronic record collection for all NICU patients and the introduction of a PCR-
based assay for viral detection rather than the immunofluorescence and culture methods used
previously. The NICUs care for all newborn infants in the Nottingham area and those
requiring intensive care from surrounding hospitals in the Trent Perinatal Network, covering
approximately 26,000 births annually. Both NICUs are part of the same organization
(Nottingham University Hospitals NHS Trust) with the same infection prevention and control
measures. Infants with VRTIs are barrier nursed in an enclosed incubator until asymptomatic.
No re-admissions are allowed once discharged from hospital after their birth. Parents could
visit anytime, with siblings and other relatives allowed between 2pm and 8pm. A restricted
visiting policy was in place during the months of November to April in 2009, 2010 and 2011
where only parents could visit as a precautionary measure in view of the H1N1 pandemic.
Visitors with respiratory illnesses were advised not to visit until symptom free.
Cases were defined as any infant cared for on the NICU whom the clinical team deemed to
have symptoms or signs consistent with a VRTI17 and had RT-PCR positive viral DNA in
airway secretions. Following resolution of symptoms, infants who became symptomatic
again with a new infection were included only if this was more than 14 days beyond the initial
positive test and with a different viral agent to reduce the risk of genomic persistence in the
airway20. Two controls were matched per case according to 1) gestation (±1 week), 2) centre
in which they received the majority of their care and 3) born within 6 months of the case to
minimise variations in care over time. All infants studied were admitted to the NICU after
birth.
Data were collected on a standardised proforma, from both the clinical notes and hospital
electronic records. Gestational age was determined by ultrasound scanning or, if this wasn’t
available, last menstrual period. Clinical data included birth weight, mode of delivery, number
of siblings, number of courses of maternal steroids, maternal infections in pregnancy,
maternal smoking, intra-uterine growth retardation and surfactant doses. Postnatal data
included time in hospital, days of respiratory support and other co-morbidities such as
congenital heart disease, retinopathy of prematurity (requiring treatment) and a clinical
diagnosis of necrotising enterocolitis (NEC).
For cases, the escalation of respiratory care was defined according to set criteria by at least
one step up the support pathway from their immediate pre-infection status: no support → 
oxygen only → continuous positive airway pressure (CPAP) → Bi-level positive airway 
pressure (BiPAP) → invasive ventilation → high frequency ventilation (HFOV) or 
extracorporeal membrane oxygenation (ECMO). BPD was defined as infants <32 weeks
gestation who require oxygen for >28 days and at 36 weeks corrected gestation21. Infants’
requirements for home oxygen were based on the criteria defined by the British Thoracic
Society22 using an agreed hospital-wide guideline.
Ethical Approval was given by the University of Nottingham Medical School Ethics
Committee, reference LTd10042014.
Sampling and RT-PCR analysis
All respiratory samples, either nasopharyngeal and/or lung aspirates if ventilated, were
collected at the time of the presumed infection and analysed using the multiplex PCR
Respiratory Viral Panel (RVP) assay according to a standard operating procedure in a
certified National Health Service (NHS) laboratory (see eTable 1 in supplement). Data were
also collected on any other positive microbiological samples found ±24 hours of the PCR
diagnosis of a VRTI.
In-hospital cost of care
Costs of care were calculated based on the 2011-12 published tariffs for neonatal care in the
UK NHS23. Costs for each level of care (intensive, high dependency and special care) were
calculated to the point of discharge or death.
Data analysis
Data were analysed using STATA v12 (Stata Corp, College Station, TX). Continuous data are
presented as means and standard deviations or medians and interquartile ranges for parametric
and non-parametric data respectively. Conditional logistic regression was used to compare the
baseline characteristics of cases and matched controls, and then to compare respiratory
outcomes including number of days of ventilation required, need for CPAP and number of days
spent in intensive care and high dependency. Univariable and multivariable logistic regression,
with a-priori adjustment for gestation and centre, was used to calculate odds ratios (ORs) for
the association between several potential risk factors and escalation in respiratory support, and
discharge on home oxygen. Potential predictors of respiratory morbidity studied included: sex;
birth weight; mode of delivery; antenatal steroids; maternal infection; chorioamnionitis;
intrauterine growth restriction; maternal smoking; surfactant; Apgar score; cardiac anomalies
(including patent ductus arteriosus); and NEC. Variables significant at the 10% significance
level (p<0.1) in a univariable logistic regression model were included in a multivariable model.
Data are summarised using ORs with 95% confidence intervals (CIs). Analyses were two-sided
and considered significant if P<0.05.
RESULTS
Baseline characteristics
During the study period, there were 7995 admissions to the NICUs where the study was
conducted (1332/year) with a total of 79,642 bed days. Two hundred and seventy five infants
(92 cases and 183 controls) met the inclusion criteria. All cases were matched with two
controls with the exception of one infant who only had a single control meeting the inclusion
criteria. Cases and controls were evenly matched with a median gestation of 29.4 weeks (IQR
26.9-33.9) for the cases and 29.6 weeks (IQR 26.9-34.0) for the controls and both had similar
baseline characteristics (Table 1).
Viral infections
There were a total of 95 nosocomial VRTIs diagnosed by PCR in 92 symptomatic infants
(Table 2). Of these, 84 (91%) were preterm with 56 (61%) ≤30 weeks gestation.  This equates 
to a symptomatic nosocomial VRTI incidence of 3.8% in infants admitted ≤30 weeks’ 
gestation. The median day of life of infection was 43 days (IQR 25-76). Rhinovirus was the
dominant pathogen and was detected in 70 cases (74%). There were five cases of Influenza A
H1N1 pandemic strain with escalation of respiratory support in three of those. There were 3
deaths before discharge in the case group, two infants with H1N1 and one with Rhinovirus.
Of note, 9 (10%) of the cases had a diagnosis of gastroschisis. A total of 23 cases had blood
cultures taken at the time of clinical deterioration, 9 were positive most for coagulase negative
staphylococcus (n=6).
Of the 95 VRTIs there were a 100 viral pathogens identified. There were more than double
the number of Rhinovirus infections in the warmer (April to September, n=47) compared to
colder months (October to March, n=23). This pattern was reversed for other viruses with 7
and 23 in the warmer and colder months, respectively.
Respiratory support
Overall, 51% (n=47) of infants required escalation of respiratory support during a VRTI
episode (Figure 1). A greater proportion of infants <28 weeks gestation required new
respiratory pressure support during the VRTI (48%) compared to those ≥28 weeks (20%, 
P<0.01). For cases, there were no associations identified with the need for escalation of
respiratory support and key patient characteristics (supplement eTable 2).
Outcomes – cases vs. controls
Cases required significantly more ventilation with a median of 7 days (IQR 2.5-27.5)
compared to 2 days (IQR 0-8) for controls (P<0.001). Similarly, cases had a greater
requirement for CPAP at a median of 18 days (IQR 1-37) compared to 5 days (IQR 0-33) for
controls (P=0.026). Cases spent significantly more care days at the level of intensive care and
high dependency as well as remaining in hospital for longer (76 days vs. 41 days, P<0.001,
Figure 2).
Amongst cases <32 weeks gestation, 65% (n=40) had a diagnosis of BPD at 28 days
compared to 52% (n=71) of controls (P=0.09) which remained not significant at 36 corrected
weeks (cases 52% vs controls 39%, P=0.81). Univariable conditional logistic regression did
not identify any clinical variables associated with VRTI at the predefined statistical level
(P<0.1) to include in a multivariable model.
Requirement for home oxygen
At time of discharge, 37% (n=34) of cases required home oxygen compared to 17.5% (n=32)
of controls (P=0.002). Cases were also more mature with a mean gestational age of 28.7
weeks (SD 4.1) compared to controls at 26.8 weeks (SD 1.8) (P=0.014). According to the
univariable analysis (logistic regression adjusted a-priori for gestation and centre of care)
clinical factors associated with the requirement for home oxygen (P<0.1) were: a confirmed
VRTI, birth weight, maternal infection, 1 minute Apgar <7, delivery room surfactant and a
cardiac anomaly. These were included in the multivariable model for home oxygen
identifying statistically significant associations with: VRTI (adjusted OR 3.94, 95% CI 1.92-
8.06, P<0.001), maternal infection (adjusted OR 2.4, 95% CI 1.12.-5.13, P=0.024), 1 minute
Apgar <7 (adjusted OR 2.17, 95% CI 1.02-4.61, P=0.047) and a cardiac anomaly (adjusted
OR 2.17, 95% CI 1.06=4.45, P=0.035).
In-hospital cost of care
The 2011 NHS tariff costs23 for intensive care, high dependency and special care were £997
($1443), £726 ($1051) and £429 ($621) per patient per day, respectively. Individual patient
costs for cases were £49,664 ($71,861) and for controls £22,155 ($32,057) (P<0.001, Figure
3). The total median cost difference between cases and controls equates to £27,509 ($39,804)
(range £1,994-£58,269 ($2,886-$84,312)) extra per patient. With less intensive and high
dependency care, 45% (n=83) of controls had care costs <£20,000 ($28,939) compared to
only 12% (n=11) of cases.
DISCUSSION
Until recently, nosocomially acquired VRTIs on the NICU were thought to be uncommon.
The present study is the largest to date and demonstrates that VRTIs on the NICU are
associated with significant respiratory morbidity, increased requirement for home oxygen, and
result in more than double the in-hospital care costs prior to first discharge. Using a rigorous
matched case-control methodology, the baseline characteristics of the infants are well
balanced supporting our belief of the validity of the results.
Neonatal patients often develop respiratory symptoms during septic episodes and are usually
screened for bacterial infection before commencement of antibiotics. Recent studies have
highlighted that either parallel screening at the time of sepsis concerns, or routine surveillance
monitoring, identify VRTI in 8 to 52% of infants in the NICU12-14. Our study has focused on
symptomatic infants with a suspected VRTI and identified the most dominant pathogen was
Rhinovirus. Other studies13,14,19 have not found this to be the dominant pathogen although
many of these were prior to the widespread use of PCR and their methodologies may not
reliably identify Rhinovirus. After respiratory syncytial virus (RSV), rhinovirus is a common
pathogen and responsible for many community respiratory infections24-26 and can cause
severe respiratory disease in older children requiring hospitalisation11,27. As the dominant
pathogen in our cases, rhinovirus was associated with a need for increased respiratory support
in half of the infants with many of the premature infants requiring additional pressure support
ventilation, similar to other smaller studies12,14,17. This results in an increase in the level of
care, barrier nursing, and requires additional nursing and medical input to manage.
Rhinovirus infection was seen throughout the year with many of the other viruses only
observed during the colder months in keeping with seasonal trends in the UK25,28.
Asymptomatic children and older individuals can have viral DNA present in their airway
secretions20,29 so parents, siblings, staff and visitors may be unaware of the infection risk they
may pose to vulnerable infants. VRTIs are known to cause more severe disease in younger
individuals30,31 which may be further exacerbated in the preterm NICU population with a
reduced trans-placental maternal IgG transfer32 and an immature immune system.
Traditionally, during periods of deterioration in preterm infants on the NICU, clinical teams
evaluate the infant for bacterial infection and commence antibiotics until bacterial cultures are
negative or the baby improves clinically. It is possible preterm infants who deteriorate on
respiratory support may actually have a VRTI but this is not considered by the attending team
as the management is mainly supportive with limited treatment options unlike bacterial
infection. Bennett14 also found VRTIs in preterm infants on the NICU were associated with
worse respiratory outcomes although, like our study, causal effect cannot be ascertained.
There is strong evidence of the adverse effects VRTIs have on preterm infants during the first
few years of life, but few studies have focused on the preterm infant at risk of BPD. The
interruption of normal lung alveolisation caused by prematurity could be further compounded
by VRTI inflammation and worsening the long-term lung injury7, potentially supporting a
causal relationship with VRTIs and respiratory morbidity in our study. This hypothesis is
supported by other studies that have demonstrated increased respiratory morbidity in preterm
infants associated with early lung infection33 and in animal models there is evidence that viral
infection, in combination with oxygen supplementation, has an adverse impact on the immune
response and potential subsequent lung recovery34. It is of interest in the present study cases
requiring home oxygen were significantly more mature, by almost 2 weeks, compared to
controls requiring home oxygen. The reasons for this are unclear but could reflect a more
mature immune system mounting a greater inflammatory response to the viral pathogen
resulting in more lung injury.
There are few published reports on neonatal nosocomial acquired H1N1 and our study adds to
the data available highlighting the significant respiratory disease this strain causes, also
evident in other outbreaks35,36. Three of the five cases of H1N1 required additional
respiratory support with two of the infants dying as a direct result of the infection. Our cases
occurred over 2 separate winters despite restricted visiting practices. Future studies could
address how best to minimise the risks to this population during global pandemics.
In this study, there were on average 15-16 VRTIs/year, mostly in preterm infants. In 2013,
there were 6236 infants born alive between 23 and 30 weeks’ gestation in England and
Wales37. Extrapolating 3.8% of these infants developing a symptomatic VRTI would equate
to 237 infants requiring an average of 35 extra days in hospital or 8295 total days. This
equates to the annual bed capacity for a 23 cot NICU. Additional NICU costs for this group
would be in the region of £6.5million (range £4.7M-£13.8M ($9.4M, $6.8M-$20M) per year.
As a greater proportion of infants go home on oxygen the on-going post-discharge healthcare
costs are also likely be significant.
Strategies aimed at reducing nosocomial VRTIs include infected patient isolation cohorts,
personal protective equipment use by staff, hand hygiene policies and restricting visitors
during periods of high community VRTI prevalence17,38,39. Few of these have been studied in
a systematic way in the NICU and further high quality studies are required. Furthermore,
many of these studies have focused on RSV but our study highlights the importance of
rhinovirus and the lack of seasonality which should be considered with any prevention
measures.
The main limitations of this study include its retrospective nature, although the data were
collected prospectively. Additionally, only infants the team felt were symptomatic were
screened for VRTI and so the overall incidence may have been greater if asymptomatic
infants were also screened. Symptom data were not collected and so the clinical diagnosis
used a pragmatic approach rather than a clearly defined definition. This study is based on
infants in only two tertiary NICUs and so the generalisability to other centres needs to be
established. However, the Nottingham NICUs during the period of study had a relatively low
rate of BPD in ventilated infants 24-32 weeks gestation according to the Trent Neonatal
Survey40 with rates significantly lower than similar units during the period 2010-12, perhaps
suggesting the present study may underestimate the impact of VRTI in other centres. More
detailed lung function data in infancy and childhood would also provide valuable long-term
data on the effects of VRTIs during early lung development.
In conclusion, this large, well matched, case-control study has demonstrated significant
respiratory morbidity and resource implications associated with nosocomial VRTIs on the
NICU. Rhinovirus was the dominant pathogen and more than 1/3 of the infants required
home oxygen. One could hypothesise that nosocomially acquired VRTIs not only contribute
to BPD in symptomatic infants but could also play a role in those infants with unrecognised
infection. With little change in the incidence of BPD, despite advances in respiratory
management, and increasing evidence that many infants have unrecognised VRTI, this is a
plausible hypothesis. Large, prospective studies could incorporate surveillance programs to
test this hypothesis. Strategies such as restricting visiting could reduce the burden of
nosocomially acquired VRTIs17 especially when the viral community load is high during
pandemics.
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Characteristic Cases n=92n (%)
Controls n=183
n (%) p Value
Male sex 49 (53) 113 (62) 0.19
Birth weight:
>2500g
1501-2500g
1000-1500g
<1000g
14 (15)
18 (20)
28 (30)
32 (35)
24 (13)
44 (24)
55 (30)
60 (33)
0.72
Antenatal steroids (full course) 64 (70) 127 (69) 0.94
Chorioamnionitis 19 (21) 48 (26) 0.27
IUGR 14 (15) 30 (16) 0.80
Maternal smoking 25 (27) 43 (23) 0.26
Mode of delivery:
Vaginal
Elective caesarean
Emergency caesarean
49 (53)
7 (8)
36 (39)
92 (50)
17 (9)
73 (40)
0.86
5 min Apgar <7 12 (13) 26 (14) 0.66
Cardiac anomaly
Of which PDA only
28 (30)
4 (4)
48 (26)
12 (15)
0.42
Necrotising enterocolitis 20 (22) 36 (20) 0.69
Retinopathy of prematurity 15 (16) 20 (11) 0.21
Death before discharge 3 (3) 13 (7) 0.26
Table 1. Baseline characteristics of study subjects. P values represent conditional
logistic regression. IUGR=Intrauterine Growth Retardation, PDA=Patent Ductus
Arteriosus
Virus n
Rhinovirus 65
Rhinovirus and Adenovirus 1
Rhinovirus and H1N1 1
Rhinovirus and Parainfluenza virus type 1 1
Rhinovirus and Parainfluenza virus type 3 1
Rhinovirus and RSV 1
Parainfluenza virus type 3 6
Respiratory Syncytial Virus (RSV) 5
Influenza A H1N1 strain 4
Coronavirus 3
Parainfluenza virus type 2 2
Others (one each of Adenovirus, Influenza A, Influenza B,
Metapneumovirus and Parainfluenza virus type 4) 5
Table 2. PCR respiratory tract viral detection in 92 infants.
Figure 1. Percentage of cases requiring escalation of respiratory support at the time
of VRTI diagnosis grouped according to birth gestation category. n=95 episodes of
infection.
Figure 2. Median (95% CI error bars) days spent at each level of care and total
hospital stay for cases (shaded boxes) compared to controls (clear boxes).
***P<0.001.
Figure 3. Median (95% CI error bars) cost according to level of care and total hospital
stay for cases (shaded boxes) and controls (clear boxes). ***P<0.001
